Xenon Pharmaceuticals Inc. (XENE) › Net IncomeXenon Pharmaceuticals Inc. (XENE) — Net IncomeAnnual figures by fiscal year, from SEC filings.2012: -$4.30M2013: $12.03M2014: $13.02M2015: -$15.75M2016: -$23.00M2017: -$30.70M2018: -$34.50M2019: -$41.59M2020: -$28.84M2021: -$78.88M2022: -$125.37M2023: -$182.39M2024: -$234.33M2025: -$345.91M-$345.91M2012Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$345.91M-47.6%2024-$234.33M-28.5%2023-$182.39M-45.5%2022-$125.37M-58.9%2021-$78.88M-173.5%2020-$28.84M+30.7%2019-$41.59M-20.6%2018-$34.50M-12.4%2017-$30.70M-33.5%2016-$23.00M-46.0%2015-$15.75M-221.0%2014$13.02M+8.2%2013$12.03M+379.7%2012-$4.30M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share